Zomedica Corp. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Zomedica Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2017 to Q2 2024.
  • Zomedica Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 980M shares, unchanged year-over-year.
  • Zomedica Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 980M shares, unchanged from 2022.
  • Zomedica Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 980M shares, a 2.45% increase from 2021.
  • Zomedica Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 957M shares, a 162% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 980M 0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 980M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 980M 0 0% Oct 1, 2023 Dec 31, 2023 10-Q 2024-05-09
Q3 2023 980M 0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 980M +50K +0.01% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 980M +50K +0.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 980M +23.4M +2.45% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 980M +1.46M +0.15% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 980M +6.24M +0.64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 980M +89.7M +10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 957M +592M +162% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 978M +428M +77.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 974M +759M +353% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 890M +772M +652% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 364M +258M +243% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 551M +443M +410% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 215M +107M +98.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 118M +17.5M +17.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 106M +12.9M +13.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 108M +13.5M +14.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 108M +15.5M +16.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 101M +10.3M +11.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 93.4M +6.04M +6.91% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 94.5M +5.67M +6.38% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 92.5M +5.45M +6.26% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 90.5M +6.1M +7.23% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 87.4M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-14
Q3 2017 88.8M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 87.1M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 84.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.